'Event free survival' presentation slideshows

Il tribunale del cardiologo: Processo allo studio della riserva coronarica Avvocato difensore

714 views • 50 slides

606 views • 44 slides

611 views • 44 slides

Reduced intensity or reduced toxicity conditioning regimens?

Reduced-toxicity conditioning with Busulfan and Fludarabine and allogeneic stem cell transplant: chimerism evaluation and global outcome of 26 consecutive patients Alessandra Algarotti Ematologia, Ospedali Riuniti, Bergamo Senigallia, 24 Ottobre 2008.

176 views • 17 slides

Objectives of the combined analysis of ABCSG Trial 8 and the German ARNO 95 trial

Benefits of switching postmenopausal women with hormone-sensitive early breast cancer to anastrozole after 2 years adjuvant tamoxifen: Combined results from 3,224 women enrolled in the ABCSG Trial 8 and the ARNO 95 trial.

337 views • 15 slides

AcademyHealth 2004 Annual Research Meeting June 8, 2004

Does Literacy Impact the Effectiveness of a Disease Management Program in Congestive Heart Failure?. AcademyHealth 2004 Annual Research Meeting June 8, 2004. Brad Smith, Robert Ellis, Emma Forkner, Richard A. Krasuski, Michael Kwan, Karl Stajduhar, Autumn Dawn Galbreath, and Gregory L. Freeman.

308 views • 13 slides

Faderl S et al. Proc ASCO 2011;Abstract 6503.

Clofarabine plus Cytarabine Compared to Cytarabine Alone in Older Patients with Relapsed or Refractory (R/R) Acute Myelogenous Leukemia (AML): Results from the Phase III CLASSIC 1 Trial. Faderl S et al. Proc ASCO 2011;Abstract 6503. CLASSIC 1 Study Design. Clofarabine 40 mg/m 2 IV

232 views • 9 slides

Supplementary Table 1 Sequences of the primer used for q-PCR analysis

250 views • 7 slides

ALKK Trial

ALKK Trial. Randomized trial of angioplasty (n=149) or medical therapy (n=151) in stable patients 8-42 days post acute MI. Survival at Long-term (mean 56 months) follow-up p=0.02. Event-free* Survival at 1 Year p=0.06. Medical Therapy. Medical Therapy. PTCA. PTCA.

141 views • 1 slides